Evidence map›Paper›PMID 33587810›Full record

ArticleJournal of thrombosis and haemostasis : JTH2021

Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response.

Liam Townsend, Helen Fogarty, Adam Dyer, Ignacio Martin-Loeches, Ciaran Bannan, Parthiban Nadarajan, Colm Bergin, Cliona O'Farrelly, Niall Conlon, Nollaig M Bourke and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 9 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 9 syntheses or guidelines pooled it, 229 citations in OpenAlex.

  1. Pooled it
  2. Prophylactic anticoagulants for non-hospitalised people with COVID-19.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. ESCMID rapid guidelines for assessment and management of long COVID.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Guideline
  7. Pooled it
  8. Pooled it
  9. Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  10. Trial
  11. Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Liam TownsendDepartment of Infectious Diseases, St James's Hospital, Dublin, Ireland.
Helen FogartyIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID 0000-0001-8161-7931
Adam DyerDepartment of Medical Gerontology, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-1356-510X
Ignacio Martin-LoechesDepartment of Intensive Care Medicine, St James's Hospital, Dublin, Ireland.
Ciaran BannanDepartment of Infectious Diseases, St James's Hospital, Dublin, Ireland.
Parthiban NadarajanDepartment of Respiratory Medicine, St James's Hospital, Dublin, Ireland.
Colm BerginDepartment of Infectious Diseases, St James's Hospital, Dublin, Ireland.
Cliona O'FarrellySchool of Medicine, Trinity College Dublin, Dublin, Ireland.
Niall ConlonDepartment of Immunology, St James's Hospital, Dublin, Ireland.
Nollaig M BourkeDepartment of Medical Gerontology, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
Soracha E WardIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Mary ByrneNational Coagulation Centre, St James's Hospital, Dublin, Ireland.
Kevin RyanNational Coagulation Centre, St James's Hospital, Dublin, Ireland.
Niamh O'ConnellNational Coagulation Centre, St James's Hospital, Dublin, Ireland.
Jamie M O'SullivanIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID 0000-0002-1162-8739
Cliona Ni CheallaighDepartment of Infectious Diseases, St James's Hospital, Dublin, Ireland.
James S O'DonnellIrish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID 0000-0003-0309-3313
St. James's Hospital · IETrinity College Dublin · IERoyal College of Surgeons in Ireland · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersistent fatigue, breathlessness, and reduced exercise tolerance have been reported following acute COVID-19 infection. Although immuno-thrombosis has been implicated in acute COVID-19 pathogenesis, the biological mechanisms underpinning long COVID remain unknown. We hypothesized that pulmonary microvascular immuno-thrombosis may be important in this context.

methodsOne hundred fifty COVID-19 patients were reviewed at St James's Hospital Dublin between May and September 2020 at a median of 80.5 (range 44-155) days after initial diagnosis. These included patients hospitalized during initial illness (n = 69) and others managed entirely as out-patients (n = 81). Clinical examination, chest x-ray, and 6-min walk tests were performed. In addition, a range of coagulation and inflammatory markers were assessed.

resultsIncreased D-dimer levels (>500 ng/ml) were observed in 25.3% patients up to 4 months post-SARS-CoV-2 infection. On univariate analysis, elevated convalescent D-dimers were more common in COVID-19 patients who had required hospital admission and in patients aged more than 50 years (p < .001). Interestingly, we observed that 29% (n = 11) of patients with elevated convalescent D-dimers had been managed exclusively as out-patients during their illness. In contrast, other coagulation (prothrombin time, activated partial thromboplastin time, fibrinogen, platelet count) and inflammation (C-reactive protein, interleukin-6, and sCD25) markers had returned to normal in >90% of convalescent patients.

conclusionsElucidating the biological mechanisms responsible for sustained D-dimer increases may be of relevance in long COVID pathogenesis and has implications for clinical management of these patients.

Indexed as

Acute-Phase ReactionAgedCOVID-19FemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedSARS-CoV-2Fibrin Fibrinogen Degradation Productsfibrin fragment Dcoagulation parameterCOVID-19D-dimerout-patient follow-up

Identifiers

PMID33587810
PMCPMC8013297
OpenAlexW3130133293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.